UBS Group’s Nobilis Health Corp. HLTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-50,844
| Closed | -$7K | – | 8535 |
|
|
2019
Q2 | $7K | Buy |
50,844
+38,640
| +317% | +$7.52K | ﹤0.01% | 7292 |
|
|
2019
Q1 | $4K | Sell |
12,204
-6,717
| -36% | -$2.78K | ﹤0.01% | 7306 |
|
|
2018
Q4 | $8K | Buy |
18,921
+15,505
| +454% | +$9.13K | ﹤0.01% | 7386 |
|
|
2018
Q3 | $3K | Sell |
3,416
-2,568
| -43% | -$2.52K | ﹤0.01% | 7702 |
|
|
2018
Q2 | $7K | Buy |
5,984
+968
| +19% | +$1.34K | ﹤0.01% | 7374 |
|
|
2018
Q1 | $8K | Hold |
5,016
| – | – | ﹤0.01% | 7039 |
|
|
2017
Q4 | $7K | Sell |
5,016
-21,364
| -81% | -$29.5K | ﹤0.01% | 7264 |
|
|
2017
Q3 | $39K | Buy |
26,380
+1,812
| +7% | +$2.87K | ﹤0.01% | 5983 |
|
|
2017
Q2 | $47K | Sell |
24,568
-6,032
| -20% | -$9.13K | ﹤0.01% | 5697 |
|
|
2017
Q1 | $52K | Sell |
30,600
-13,702
| -31% | -$28.5K | ﹤0.01% | 5505 |
|
|
2016
Q4 | $93K | Sell |
44,302
-15,194
| -26% | -$41.4K | ﹤0.01% | 5349 |
|
|
2016
Q3 | $199K | Buy |
59,496
+18,496
| +45% | +$55.6K | ﹤0.01% | 4553 |
|
|
2016
Q2 | $91K | Sell |
41,000
-5,044
| -11% | -$16.4K | ﹤0.01% | 5098 |
|
|
2016
Q1 | $144K | Buy |
46,044
+1,785
| +4% | +$4.62K | ﹤0.01% | 4718 |
|
|
2015
Q4 | $125K | Buy |
44,259
+259
| +0.6% | +$828 | ﹤0.01% | 5042 |
|
|
2015
Q3 | $230K | Buy |
+44,000
| New | +$253K | ﹤0.01% | 4521 |
|
Other funds holding HLTH
UBS Group's HLTH Position: Q3 2019 in Review
UBS Group sold out of Nobilis Health Corp. (HLTH) in Q3 2019, closing a stake of 50,844 shares — an estimated $7K sold.
UBS Group first reported a position in HLTH in Q3 2015 and held it in 16 quarters. The position peaked at $230K in Q3 2015. 3 funds tracked by Wall St. Rank hold HLTH as of Q3 2019.
- UBS Group reported no remaining Nobilis Health Corp. position as of Q3 2019 after selling out during the quarter.
- UBS Group sold 50,844 Nobilis Health Corp. shares in Q3 2019, an estimated $7K.
- UBS Group first reported a position in Nobilis Health Corp. in Q3 2015 and held it in 16 quarters.
- UBS Group's Nobilis Health Corp. position peaked at $230K in Q3 2015.
- 3 funds tracked by Wall St. Rank held Nobilis Health Corp. as of Q3 2019.
Based on UBS Group's 13F filing for Q3 2019, filed 14 Nov 2019.